[Source]
CHARLOTTE, NC. – April 24, 2012 – Metro Charlotte-based, Ei, A Pharmaceutical SolutionWorksÔ announced that it now has minoxidil in a convenient sprayer version available for private label and branded customers. Minoxidil, which was first used as an oral drug to treat high blood pressure, was later found to induce hair growth. When formulated into a topical solution and applied to the scalp, minoxidil demonstrates statistical significance in increasing hair growth in both men and women. Minoxidil is the only FDA approved product available without a prescription that is proven to grow hair.
Ei is now producing a minoxidil sprayer, as well as the original dropper product in both 2% and 5% formulations. Ei’s minoxidil sprayer features a patented, child-resistant sprayer making it compliant with current US Consumer Product Safety Commission guidelines. The regulatory and licensing process for new products is long, costly and often tenuous. Ei allows their customers to eliminate the wait, high cost and uncertainty and begin to produce FDA approved and regulated, high-quality minoxidil. Not only can Ei produce the minoxidil product, but as A Pharmaceutical SolutionWorksÔ they can package and ship these products with customized graphics using regulatory approved labeling.
Roger Martin, Sr. Vice President of Sales and Marketing for Ei, states, “Ei is excited to bring additional innovation and value to our customers through this unique minoxidil product offering. We strive to build value into our partnerships by delivering the highest level of quality and service, coupled with on-site regulatory expertise and turnkey operations. Whether an Rx, OTC, or therapeutic skin care product, our unwavering goal is to help protect and grow our customers’ brand.”
About Ei
Based in metro Charlotte, North Carolina, Ei, A Pharmaceutical SolutionWorksÔ develops and manufactures topical liquid, semi-solid and loose powder lines for Rx, OTC, therapeutic skin care and animal health products for a wide range of brands. The company operates 180,000 square feet of state-of-the-art manufacturing facilities. Ei offers topical drug product expertise and turn-key project management including formula development, package sourcing, testing, method development, validation, ICH stability programs, bulk manufacturing, filling and regulatory filing assistance. Ei represents over 50 customers with a strong concentration of multi-national, top-tier pharmaceutical and therapeutic skin care companies and other Fortune 100 companies. Ei is privately held and was founded in 1983. www.eisolutionworks.com
# # #
Contact:
Kendria Sweet, 704.533.3796, [email protected]